Abstract

The actinomycins are a family of chromopeptide antibiotics isolated from various Streptomyces strains. First isolated in 19401, they were found in 1952 to possess antitumour activity2 and were introduced clinically3. They have been used mainly in the treatment of Wilm’s tumour4, choriocarcinoma5 and embryonal testicular carcinoma6; the clinical applications have been reviewed7,8. All contain the same phenoxazinone chromophore (red, max. 445 nm) attached amide-wise to two variable pentapeptide lactone units9. The best known example is actinomycin D (AMD, Figure 17.1)10 and analogues will be abbreviated by reference to this structure. The natural variants and artificial analogues and their comparative biological activities have been reviewed11,12, covering the literature up to 1979. In what follows, references cited in those reviews are not repeated.

Keywords

Streptomyces Strain Anti Tumour Pipe Colic Acid ANTITUMOUR Agent Partial Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. A. Waksman and H. B. Woodruff, Proc. Soc. Exp. Biol. Med. 45 (1940) 609.Google Scholar
  2. 2.
    C. Hackmann, Z. Krebsforsch. 58 (1952) 607.CrossRefGoogle Scholar
  3. 3.
    G. Schulte, Z. Krebsforsch. 58 (1952) 500.CrossRefGoogle Scholar
  4. 4.
    S. Farber and A. Mitus, in Chemotherapy of Cancer, ed. W.H. Cole, Lea and Febiger, Philadelphia (1970) p. 277.Google Scholar
  5. 5.
    G. T. Ross, L. L. Stohlbach and R. Herz, Cancer Res. 22 (1962) 1015.Google Scholar
  6. 6.
    A. R. MacKenzie, Cancer 19 (1966) 1369.CrossRefGoogle Scholar
  7. 7.
    E. Frei, III, Cancer Chemother. Rep. Part 1 58 (1974) 49.Google Scholar
  8. 8.
    T. G. Terent’eva, L. V. Egorov and N. I. Perevodchikova, Antibiot. Med. Biotekhnol. 30 (1985) 619.Google Scholar
  9. 9.
    H. Brockmann, G. Bohnsack, B. Franck, H. Grone, H. Muxfeldt and C. Siiling, Angew. Chem. 68 (1956) 70.Google Scholar
  10. 10.
    E. Bullock and A. W. Johnson, J. Chem. Soc. (1957) 3280.Google Scholar
  11. 11.
    J. Meienhofer and E. Atherton, in Structure-Activity Relationships among the Semisynthetic Antibiotics, ed. D. Perlman, Academic Press, New York (1977) p. 427.Google Scholar
  12. 12.
    A. B. Mauger, Top. Antibiot. Chem. 5 (1980) 223.Google Scholar
  13. 13.
    S. C. Jain and H. M. Sobell, J. Mol. Biol. 68 (1972) 1.CrossRefGoogle Scholar
  14. 14.
    F. Takusagawa, M. Dabrow, S. Neidle and H. M. Berman, Nature (London) 296 (1982) 466.CrossRefGoogle Scholar
  15. 15.
    F. Takusagawa, B. M. Goldstein, S. Youngster, R. A. Jones and H. M. Berman, J. Biol. Chem. 259 (1984) 4714.Google Scholar
  16. 16.
    S. Ginell, L. Lessinger and H. M. Berman, Biopolymers 27 (1988) 843.CrossRefGoogle Scholar
  17. 17.
    F. Takusagawa, J. Antibiot. 38 (1985) 1596.Google Scholar
  18. 18.
    H. M. Sobell, Proc. Natl. Acad. Sci. USA 82 (1985) 5328.CrossRefGoogle Scholar
  19. 19.
    H. Nakazawa, F. E. Chou, P. A. Andrews and N. R. Bachur, J. Org. Chem. 46 (1981) 1493.CrossRefGoogle Scholar
  20. 20.
    U. Keller, J. Biol. Chem. 259 (1984) 8226.Google Scholar
  21. 21.
    A. B. Mauger, O. A. Stuart, J. A. Ferretti and J. V. Silverton, J. Am. Chem. Soc. 107 (1985) 7154.CrossRefGoogle Scholar
  22. 22.
    R. K. Sehgal, S. K. Sengupta, D. J. Waxman and A. I. Tauber, Anticancer Drug Design 1 (1985) 13.Google Scholar
  23. 23.
    S. K. Sengupta, J. E. Anderson, Y. Kogan, D. H. Trites, W. R. Beltz and M. S. Madhavarao, J. Med. Chem. 24 (1981) 1052.CrossRefGoogle Scholar
  24. 24.
    B. K. Sinha, M. G. Cox and C. F. Chignell, J. Med. Chem. 22 (1979) 1051.CrossRefGoogle Scholar
  25. 25.
    S. K. Sengupta, C. Kelly and R. K. Sehgal, J. Med. Chem. 28 (1985) 620.CrossRefGoogle Scholar
  26. 26.
    S. K. Sengupta, J. E. Anderson and C. Kelly, J. Med. Chem. 25 (1982) 1214.CrossRefGoogle Scholar
  27. 27.
    S. K. Sengupta, J. Blondin and J. Szabo, J. Med. Chem. 27 (1984) 1465.CrossRefGoogle Scholar
  28. 28.
    R. K. Sehgal, B. Almassian, D. P. Rosenbaum, R. Zadrozny and S. K. Sengupta, J. Med. Chem. 30 (1987) 1626.CrossRefGoogle Scholar
  29. 29.
    R. K. Sehgal, B. Almassian, D. P. Rosenbaum, R. Zadrozny and S. K. Sengupta, J. Med. Chem. 31 (1988) 790.CrossRefGoogle Scholar
  30. 30.
    M. V. Mikhailov, S. M. Nikitin, A. S. Zasedatelev, A. Z. Zhuze, G. V. Gurskii and B. P. Gottikh, Mol. Biol. (Moscow) 13 (1979) 1322.Google Scholar
  31. 31.
    S. M. Nikitin, S. L. Grokhovskii, A. L. Zhuze, M. V. Mikhailov, A. S. Zasedatelev, G. V. Gurskii and B. P. Gottikh, Bioorg. Khim. 7 (1981) 542.Google Scholar
  32. 32.
    M. V. Mikhailov, S. M. Nikitin, A. L. Zhuze, A. S. Zasedatelev, G. V. Gurskii and B. P. Gottikh, FEBS Lett. 136 (1981) 53.CrossRefGoogle Scholar
  33. 33.
    S. K. Sengupta, M. S. Madhavarao, C. Kelly and J. Blondin, J. Med. Chem. 26 (1983) 1631.CrossRefGoogle Scholar
  34. 34.
    S. K. Sengupta, Y. Kogan, C. Kelly and J. Szabo, J. Med. Chem. 31 (1988) 768.CrossRefGoogle Scholar

Copyright information

© Blackie & Son Ltd 1990

Authors and Affiliations

  • A. B. Mauger

There are no affiliations available

Personalised recommendations